Graduate Certificate -Visual Neuroplasticity, 2003, Otto von Guericke University, Madgeburg, Germany
OD, 1997, Nova Southeastern University College of Optometry
BS, 1995, Nova Southeastern University College of Optometry
Fellow, 2004, International Association of Rehabilitation Professionals
Honorable Discharge, United States Marine Corps 1987
Lange Eye Institute, Gainesville, FL
10/2009 to 1/2011
Senior Associate, Director of Clinical Research
Health Research Sciences, LLC, Lighthouse Point, FL
9/2009 to Present, Chief Medical Officer
NovaVision Inc., Boca Raton, FL.
7/2003 to 9/2009 Director of Clinical Affairs
Brevard Eye Center, Melbourne, FL
1998-2003, Associate Medical Optometrist
Staff Optometrist, Western University of Health Sciences Eye Care Center, Pomona, CA
Consulting, visiting Optometrist, RockyCreek/Rescare Residences for the Developmentally Disabled, Los Angeles and San Bernadino Counties
If you can take the most complex subject and successfully translate it into simple, understandable, and vivid terms, then you are a teacher.
California Optometric Association (COA)
Neuro-Optometric Rehabilitation Association (NORA)
International Association of Rehabilitation Professionals (IARP)
Co-author “Schulz P, Romano JG, Kenkel S, Todd, DP. “Visual field changes after a
rehabilitation intervention: Vision restoration therapy”
Journal of the Neurological Sciences, Volume 273, Issue 1, Pages 70-74
Co-author “Schulz P, Romano JG, Kenkel S, Todd, DP. Visual field changes after Vision
Restoration Therapy (VRT) in a US population. International Stroke Conference 2007. San
Diego, California, February 6-9, 2007 (abstract), American Academy of Neurology, Platform
Presentation, Boston Massachussetts, April 28-May 5 2007.
Author of COPE approved 1 hour CME course “An Overview of Glaucoma Drugs”.
Author of COPE approved 1 hour CME course “Automated Perimetry, The Basics of Visual
Author of COPE Approved 1 hour CME course ”Cortical Remapping in Central Scotoma
Patients, A New Therapy Paradigm”.
Author of COPE approved 2 hour CME course “Reduction of Homonymous Visual Field
Defects with Computer Based Vision Restoration Therapy”
Author of COPE approved 2 hour CME course “Current Science and Methods in Cortical
Visual Field Loss”.
Author of Florida, Alabama, and Georgia Board approved CME course “Ocular Vasculature
in Systemic Disease”.
Author of JCAHPO approved CME course “Systemic Meds for the Para-Optometric”
Author of Florida Board approved CME course “Laser Scanning Polarimetry in Glaucoma”
Author of Florida Board approved CME course “Everything You always wanted to know
about the ORBSCAN II but were afraid to ask”
Editorial Commentary “Frequent Replacement Hydrogels in Extended Wear” accepted for
publication by Ophthalmology. Published in January 2000.
Co-developer of new computer based visual attention and eccentric fixation therapy for
central scotoma patients. Currently in pilot study at Atlanta V.A. and Bascom Palmer Eye
Institute,West Palm Beach, FL.
Holder of multiple patents and patents pending (U.S. and Europe) for several innovations in
stimuli algorithms for detection of vision loss, visual field testing and visual field restoration
Dr. Todd chose Western University to begin his academic life after a 15-year career spanning a wide variety of optometric experiences. He completed his pre-medical studies at the competitive Health Careers Program at Harvard’s College of Extension Studies. He graduated with honors with an O.D. degree from Nova Southeastern University, College of Optometry. In the years that followed, Dr. Todd concentrated his characteristic energy working in ophthalmology centers, LASIK treatment centers, rural eye care in the Deep South, inpatient treatment of nursing home, brain injury and developmentally disabled patients and as a developer of new technologies for biotech companies. He currently holds several U.S. and European patents, has been published in refereed medical journals and is a member of The Mensa Society. Now at Western, Dr. Todd enjoys what he calls “whole person eye care” and Western’s partnership with industry in developing new methods and technologies.